These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15166528)

  • 1. Chronic HIV-2 infection protects against total CD4+ cell depletion and rapid disease progression induced by SHIV89.6p challenge.
    Otten RA; Adams DR; Kim CN; Pullium JK; Sawyer T; Jackson E; Folks TM; Butera S
    AIDS; 2004 May; 18(8):1127-35. PubMed ID: 15166528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.
    Doria-Rose NA; Ohlen C; Polacino P; Pierce CC; Hensel MT; Kuller L; Mulvania T; Anderson D; Greenberg PD; Hu SL; Haigwood NL
    J Virol; 2003 Nov; 77(21):11563-77. PubMed ID: 14557642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells.
    Matrajt L; Younan PM; Kiem HP; Schiffer JT
    J Virol; 2014 Mar; 88(6):3202-12. PubMed ID: 24390339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin.
    Okamura T; Tsujimura Y; Soma S; Takahashi I; Matsuo K; Yasutomi Y
    J Gen Virol; 2016 Dec; 97(12):3413-3426. PubMed ID: 27902330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of restricted CD4 T cell expansions in SIV-infected macaques resistant to SHIV89.6P superinfection.
    Salha MD; Cheynier R; Halwani R; McGrath H; Langaee TY; Yassine Diab B; Fournier J; Parenteau M; Edgar J; Ko D; Sherring A; Bogdanovic D; Sekaly RP; Rud EW
    Virology; 2008 Aug; 377(2):239-47. PubMed ID: 18570962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques.
    Villinger F; Switzer WM; Parekh BS; Otten RA; Adams D; Shanmugam V; Bostik P; Mayne AE; Chikkala NF; McClure HM; Novembre F; Yao Q; Heneine W; Folks TM; Ansari AA
    Virology; 2000 Dec; 278(1):194-206. PubMed ID: 11112494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.
    Hofmann-Lehmann R; Vlasak J; Rasmussen RA; Smith BA; Baba TW; Liska V; Ferrantelli F; Montefiori DC; McClure HM; Anderson DC; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Katinger H; Stiegler G; Cavacini LA; Posner MR; Chou TC; Andersen J; Ruprecht RM
    J Virol; 2001 Aug; 75(16):7470-80. PubMed ID: 11462019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of apoptosis induction in both peripheral lymph nodes and thymus in progressive loss of CD4+ cells in SHIV-infected macaques.
    Iida T; Ichimura H; Shimada T; Ibuki K; Ui M; Tamaru K; Kuwata T; Yonehara S; Imanishi J; Hayami M
    AIDS Res Hum Retroviruses; 2000 Jan; 16(1):9-18. PubMed ID: 10628812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathogenesis of chimeric simian human immunodeficiency virus infection in rhesus macaques.
    Buch S; Pinson D; Hou Y; Adany I; Li Z; Mukherjee S; Jia F; Mackay G; Silverstein P; Kumar A; Narayan O
    J Med Primatol; 2000 Aug; 29(3-4):96-106. PubMed ID: 11085571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model.
    Batten CJ; De Rose R; Wilson KM; Agy MB; Chea S; Stratov I; Montefiori DC; Kent SJ
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):580-8. PubMed ID: 16796533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge.
    Frenkel LM; Kuller L; Beck IA; Tsai CC; Joy JP; Mulvania TM; Hu SL; Montefiori DC; Anderson DM
    PLoS One; 2021; 16(4):e0240495. PubMed ID: 33914754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.
    Richardson MW; Sverstiuk AE; Silvera P; Greenhouse J; Lisziewicz J; Lori F; Khalili K; Lewis MG; Rappaport J
    DNA Cell Biol; 2004 Jan; 23(1):1-13. PubMed ID: 14965468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.
    Pullium JK; Adams DR; Jackson E; Kim CN; Smith DK; Janssen R; Gould K; Folks TM; Butera S; Otten RA
    J Infect Dis; 2001 Apr; 183(7):1023-30. PubMed ID: 11237826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected Chinese rhesus macaques.
    Tian RR; Zhang MX; Zhang LT; Zhang XL; Zheng HY; Zhu L; Pang W; Zhang GH; Zheng YT
    Arch Virol; 2015 Aug; 160(8):1953-66. PubMed ID: 26036562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigene DNA prime-boost vaccines for SHIV89.6P.
    Doria-Rose NA; Pierce CC; Hensel MT; Sutton WF; Sheikh N; Polacino P; Kuller L; Zhu YD; Hu SL; Anderson D; Haigwood NL
    J Med Primatol; 2003 Aug; 32(4-5):218-28. PubMed ID: 14498982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
    Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
    Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.